TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive Breast Cancer Coalition Widens Its Agenda For Advocacy, Vows To Fight NIH Cutbacks May 5, 1995